What Datacubed Health does

Datacubed Health is a private clinical research technology company founded in 2016 and headquartered in King of Prussia, Pennsylvania (with a historical principal office in Brooklyn, New York and a Delaware LLC entity, Data Cubed, LLC). The company provides an adaptive electronic clinical outcome assessment (eCOA) and electronic patient-reported outcome (ePRO) platform used in pharmaceutical, biotech, and academic clinical trials across 60+ countries and 100+ languages. Its product suite combines core platform modules — eCOA/ePRO, Patient Engagement Solutions, eConsent, Connected Sensors and Integrations, and Reports and Dashboards — with delivery services (Expert Consulting, Project Management, Translations) and therapeutic-area configurations for oncology, respiratory, CNS, and metabolic studies. Underlying technology emphasizes a no-code adaptive architecture, BYOD or provisioned device flexibility, integration with EDC, CTMS, EHR, RTSM, Apple Health, Google Fit, and clinical-grade medical devices, and a behavioral science-driven engagement engine with optional gamification reported to drive 85%+ retention and 90%+ compliance. Datacubed holds itself out as compliant with 21 CFR Part 11, HIPAA, GDPR, and ISO 27001, and cites 500+ deployments since founding, 90%+ sponsor satisfaction, 90%+ on-time study launches, and 99.9% uptime as evidence of operational maturity.

The company sells primarily through enterprise field sales targeting pharmaceutical sponsors, CROs, and academic medical centers on quote-based, multi-year study contracts, supplemented by channel partnerships (notably Advarra's Study Collaboration ecosystem) and API-first integrations into sponsor and CRO technology stacks. Named or referenced customers include Janssen (Johnson & Johnson), a Top 10 global pharmaceutical company, Centricity Research, ATCOR Medical, the ALLFTD Consortium, the University of California San Francisco, and Washington University. Leadership transitions include the appointment of Kyle Hogan as CEO in May 2024 (succeeding founder Brett Kleger, who remains an investor and advisor) and Vikram Natarajan as CTO in February 2024, alongside Executive Chairman Marc Eigner and Board member Jackie Kent. Capital formation includes a $10 million SEC Form D exempt offering filed in February 2023, with reported 150% year-over-year revenue growth in 2022, though Datacubed does not publicly disclose revenue, valuation, or active study counts.

Name

Datacubed Health

Legal name

Data Cubed, LLC

Website

https://datacubed.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Datacubed Health provides an adaptive, behavioral science-driven eCOA and ePRO platform for clinical trials, serving pharmaceutical sponsors, CROs, and academic medical centers with 500+ deployments across 60+ countries and therapeutic-area-specific solutions in oncology, CNS, respiratory, and metabolic studies.

Ownership category

akta.pro rank

Product category

Clinical Trial eCOA/ePRO Software

NAICS

Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

akta.pro secondary industries

Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

Keywords

• Clinical trial eCOA
• Electronic patient outcomes
• Decentralized clinical trials
• EConsent software
• Clinical research technology

Headquarters

HQ city

Brooklyn

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. eCOA/ePRO Platform Licensing: Software licensing for electronic clinical outcome assessment and patient-reported outcomes data collection, configured per protocol and deployed across global clinical trials. Revenue is generated through study-based engagements with pharmaceutical sponsors, CROs, and academic research institutions.
2. Clinical Data Technology Services: Expert consulting, project management, configuration, translations, and ongoing support services bundled with platform deployment. Services include study architecture and design, compliance preparation, global deployment, training, and 24/7 multilingual help desk support.
3. Connected Device and Sensor Integrations: Integration services and data flows connecting wearables, medical devices, and site systems with the Datacubed platform through API-first architecture.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Datacubed Health provides an electronic clinical outcome assessment (eCOA) and electronic patient-reported outcome (ePRO) platform for clinical trials, featuring adaptive design architecture, behavioral science-driven patient engagement, eConsent, connected sensors and wearables integration, and real-time compliance dashboards. The platform supports decentralized, hybrid, and site-based trial models with BYOD or provisioned device flexibility, and is used by pharmaceutical sponsors, CROs, and academic medical centers globally.

Product overview

Datacubed Health offers a unified clinical research technology ecosystem combining a core platform with modular components. The portfolio includes eCOA and ePRO Solution (the primary data capture platform), Patient Engagement Solutions (behavioral science-powered engagement engine), eConsent Software (digital consent with multimedia support), Connected Sensors & Integrations (API-first integration hub), and Reports & Dashboards (real-time oversight). These core products are supported by Delivery & Success service modules: Expert Consulting, Fit-for-Purpose Architecture, Project Management & Support, and Translations (100+ languages). Specialized therapeutic area solutions cover Oncology, Respiratory, CNS, and Metabolic trials, each with configurable workflows adapted to the specific demands of each condition. The platform operates on a single unified architecture that adapts to decentralized, hybrid, or site-based trial models without custom code.

Differentiator

Problem solved

Functional benefit

Products and services

• eCOA and ePRO Solution Mobile-first electronic clinical outcome assessment and patient-reported outcome platform with adaptive design, behavioral science-driven engagement, and real-time data capture. Supports PRO, ClinRO, ObsRO, and PerfO assessments with BYOD or provisioned device flexibility for pharmaceutical sponsors, CROs, and academic research institutions.
• Patient Engagement Solutions Behavioral science-powered engagement engine integrated into the platform, featuring optional gamification, custom avatars, progress tracking, milestone celebrations, and adaptive nudges designed to sustain motivation and improve retention in clinical trial participants.
• eConsent Software Digital informed consent solution with multimedia support, plain-language explanations, comprehension assessments, and IRB-ready workflows. Features BYOD access, version tracking, and full compliance with 21 CFR Part 11, HIPAA, and GDPR for clinical trial enrollment.
• Connected Sensors and Integrations API-first integration hub connecting wearables, medical devices, EDC systems, and site tools. Supports Apple Health, Google Fit, clinical-grade devices such as spirometers, glucometers, ECGs, and scales, with real-time or scheduled data flows.
• Reports and Dashboards Real-time, customizable dashboards providing cross-study visibility into compliance, retention, site performance, and device usage. Includes role-specific views for sponsors, CROs, and sites with automated quality checks and audit-ready exports.
• Oncology eCOA/ePRO Solution Cycle-based architecture designed for oncology trials with instant flexibility for individualized treatment plans, seamless adjustments for dose holds and reductions, and unified dashboards for cycle progress and compliance trends.
• Respiratory eCOA/ePRO Solution Mobile-first daily diary solution for respiratory studies with seamless device integrations including smart inhaler sensors and spirometry, real-time adherence intelligence, and configurable intervals for site and sponsor review.
• CNS eCOA/ePRO Solution Cognitive-accessible UX platform for CNS trials featuring BYOD flexibility, remote and hybrid workflows, gamified cognitive tasks, caregiver and clinician pathways, and validated digital instruments for cognitive and behavioral endpoints.
• Metabolic eCOA/ePRO Solution Longitudinal lifestyle tracking platform for metabolic trials with daily diaries, adaptive reminders, connected device integrations including glucose monitors, smart scales, and wearables, with behaviorally informed nudges for sustained participant motivation.
• Expert Consulting Strategic consulting service for protocol design, digital workflow translation, and regulatory alignment. Includes 7-10 weeks average time from setup to go-live and QMS/SOPs ready for sponsor and CRO audits.
• Fit-for-Purpose Architecture Modular, compliance-first platform architecture that adapts to any therapeutic area, workflow, country, or scale. Supports decentralized, hybrid, and site-based trials with cycle-based or milestone-based protocols.
• Project Management and Support Dedicated project management team providing 90%+ on-time study launches, 24/7 support across time zones, and 90%+ sponsor satisfaction scores. Covers kickoff through close out with real-time monitoring and proactive risk surfacing.
• Translations Scientifically validated ePRO and eCOA translations across 100+ languages and 60+ countries. Integrates directly into platform setup with culturally intelligent localization and compliance with global regulatory standards.

Quantifiable outcome

• 85%+ patient retention rates demonstrated across clinical trials
• +7 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability1 record

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• AdvarracoreTechnology or Integration · 10 December 2025Datacubed joined Advarra's expanded Study Collaboration solution as an eClinical technology partner, enabling sponsors, CROs, and research sites to access Datacubed's eCOA and ePRO through single sign-on alongside other integrated technologies including EDC, eConsent, IRT/RTSM, eCOA, payments, and patient engagement tools. The integration aims to reduce administrative burden, improve adoption, and strengthen security through centralized access controls for over 225,000 study team members already using the platform.
• ATCOR MedicalminorStrategic or Co-development Partner · 26 June 2023Partnership agreement between ATCOR Medical and Datacubed Health to increase patient retention and engagement in decentralized clinical trials, combining ATCOR's medical device technology with Datacubed's patient engagement platform.
• Special Forces Combat Veterans (Research Collaboration)minorStrategic or Co-development Partner · 15 June 2023Collaboration with Special Forces Combat Veterans to conduct a revolutionary post-traumatic stress study, applying Datacubed's clinical trial technology to mental health research.
• Washington UniversityminorStrategic or Co-development Partner · 1 January 2019Washington University's Alzheimer's study adopted Datacubed's BYOD technology for remote monitoring and clinical trials, enabling participants to use their own devices for data collection.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Veeva Systems: Veeva's Vault Clinical Suite (including Vault ePRO) targets the same pharma sponsors and CROs with a broader enterprise platform. While Veeva's eCOA module is less specialized than Datacubed's, its deep enterprise footprint and CRM dominance make it a meaningful competitive threat on multi-product deals.
• IQVIA: IQVIA's eCOA and patient-centric technologies sit within its much larger eClinical and CRO services portfolio. As the world's largest CRO, IQVIA competes with Datacubed both as an eCOA vendor and as a service provider, leveraging scale, sponsor relationships, and bundled offerings that Datacubed cannot match as a standalone platform.

Direct peers

• Signant Health: Signant Health (formed from the merger of CRF Health and Bracket) is a specialized eCOA/ePRO vendor serving pharma sponsors and CROs. It overlaps directly with Datacubed's core offering, including BYOD, connected sensors, and behavioral patient engagement, and competes in similar therapeutic areas with comparable global delivery capability.
• YPrime: YPrime offers eCOA, IRT, and eClinical solutions with a particular focus on configurable, patient-friendly data collection. Both YPrime and Datacubed target similar mid-to-large pharma sponsors with mobile-first eCOA platforms, making it a close comparable on product architecture and go-to-market motion.
• Kayentis: Kayentis is a France-based eCOA/ePRO specialist serving global clinical trials across oncology, respiratory, and CNS. Its therapeutic-area verticalization and multi-language deployment capability closely mirror Datacubed's positioning, and it competes head-to-head on European enterprise accounts.
• Medidata Solutions (Dassault Systèmes): Medidata Rave eCOA is a direct competitor offering electronic clinical outcome assessments within the broader Rave eClinical suite. Both companies target pharmaceutical sponsors and CROs with API-driven, multi-therapeutic eCOA platforms, and Medidata's scale and EDC bundling make it the most direct head-to-head competitor to Datacubed.
• Clario: Clario (formerly ERT/BIOPAR) provides eCOA, ePRO, and connected sensor solutions for clinical trials across respiratory, CNS, and oncology indications. It competes directly with Datacubed on BYOD flexibility, medical device integration, and global deployment scale, with deeper resources as a result of private equity backing.

Others

• Advarra: Advarra is a provider of IRB, study collaboration, and eClinical enablement technologies that recently integrated Datacubed as an eCOA/ePRO partner. While primarily complementary (and now a channel partner), Advarra's broader eClinical ambitions position it as a potential ecosystem competitor over time.

Emerging players

• Castor: Castor is an eClinical platform offering EDC, ePRO, eConsent, and DCT tooling to academic and commercial sponsors. Its lower-cost, self-service orientation targets smaller studies that may not match Datacubed's enterprise sweet spot, but it increasingly overlaps on pharma-sponsored trials seeking flexible eCOA solutions.
• Medable: Medable is a decentralized clinical trial platform offering eCOA, eConsent, telehealth, and remote patient monitoring. While broader than Datacubed's eCOA focus, it increasingly competes on the same RFPs for DCT-enabling technology stacks and has raised significantly more capital to scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/datacubedhealth
• LinkedInlinkedin.com/company/datacubedhealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Datacubed Health